Skip to main content

Genetic testing

APOE testing: the debate

The Alzheimer’s risk gene test - why it is both scientifically real and, for most people, still not clinically recommended.

Key facts

At a glance

  • The science is real: APOE e4 raises Alzheimer’s risk - one copy severalfold, two copies substantially more - but it is a risk factor, not a diagnosis.

  • Neither necessary nor sufficient: many e4 carriers never develop dementia, and many people with Alzheimer’s carry no e4 at all.

  • Why guidelines hesitate: with no proven preventive drug for carriers, the result rarely changes advice - what helps carriers helps everyone.

  • A shifting landscape: new anti-amyloid drugs use APOE status for treatment safety decisions, giving the test a genuine clinical role in that setting.

  • Follow-up: if you are considering testing - or have a consumer result - counselling helps place the number without either panic or false reassurance.

The full picture

What this test involves, and how to get it

APOE is the most consequential common gene in Alzheimer’s risk, and the debate about testing healthy people is a debate about usefulness, not validity. The e4 variant of APOE raises risk in dose fashion - one copy (about a quarter of the population) increases lifetime risk severalfold, two copies (2-3%) considerably more - while the e2 variant is modestly protective. Yet APOE is probabilistic on both flanks: many e4 carriers reach old age cognitively intact, and a substantial share of Alzheimer’s occurs in people with no e4 at all. That asymmetry - real information, weak actionability - is why professional guidance has long advised against routine predictive APOE testing in asymptomatic people: the evidence-based responses to a bad result (exercise, blood pressure control, hearing care, sleep, metabolic health) are exactly what everyone should do anyway.

The landscape is honestly shifting at one edge: the new anti-amyloid antibody treatments use APOE genotype to stratify the risk of brain swelling and bleeding side effects, so within memory clinics assessing people with actual symptoms, APOE testing has acquired a legitimate clinical role. For asymptomatic people, consumer kits will happily report APOE - and those who test should do so eyes-open, ideally with counselling before rather than after, covering the psychological research (most people cope, some do not), the family implications, and the UK insurance code under which predictive results are not requested at standard cover levels. If concern about memory - your own or a parent’s - is what is really driving the question, a memory clinic assessment answers it better than a genotype: NHS via GP referral, or privately within weeks.

A quiet reminder

This guide is for information, not medical advice.

Your own clinician knows your history and can tell you which parts apply to you. Next review of this page: 2027-09-27.

Frequently asked

Common questions about APOE testing: the debate.

Quick, plain-English answers to what people ask us most.

  • What is APOE testing: the debate and what does it claim to offer?

    APOE testing: the debate refers to a test or approach that is marketed as giving insight into a particular aspect of health, though the strength of the underlying scientific evidence varies and is genuinely debated among clinicians. It's important to understand what a test can and can't reliably tell you before deciding whether it's worth pursuing. A balanced conversation with a doctor can help set realistic expectations.

  • Is there good scientific evidence behind it?

    The evidence base for this type of test is mixed, and mainstream clinical guidelines in the UK generally do not recommend it as a reliable basis for diagnosis or treatment decisions. Some studies show associations or potential, but this hasn't translated into the kind of robust, reproducible evidence needed for routine clinical use. This doesn't mean it's without any value, but it does mean results should be interpreted cautiously.

  • Do I need to prepare for it?

    Preparation requirements vary by provider, and you should always follow the specific instructions given at booking rather than assuming. Because this isn't a standardised NHS test, protocols can differ more between providers than with well-established tests. It's worth asking the provider directly what preparation, if any, is expected.

  • What actually happens during the test?

    This typically involves a sample of some kind — often blood, hair, or saliva depending on the specific test — which is then sent for laboratory analysis. The process itself is usually quick and low-risk. The main consideration is less about the test procedure and more about how much weight to place on the result afterwards.

  • Are there any risks in having this test done?

    The physical risk of sample collection is minimal. The more relevant risk is being given an unhelpful or misleading result that leads to unnecessary worry, unproven treatments, or unnecessary dietary or lifestyle restrictions. Discussing results with a doctor before making any significant changes is strongly recommended.

  • How long does it take to get a result?

    Turnaround times vary by provider, but many report results within a couple of weeks. Because this isn't a standard NHS pathway, timeframes and reporting formats can differ noticeably between providers. Check with the specific provider for their expected timeframe.

  • What should I do if the result suggests a problem?

    Given the mixed evidence base, it's important not to act on results in isolation — discuss any findings with a doctor before making significant health, dietary or lifestyle decisions. A doctor can help you understand which findings, if any, are clinically meaningful and worth acting on. Avoid stopping medication or making major changes based solely on this kind of result without medical input.

  • Is this available on the NHS?

    This type of test is generally not offered on the NHS, largely because current evidence doesn't support its routine clinical use. It's typically only available privately, and cost varies by provider. This is worth bearing in mind when weighing up whether to pursue it.

  • How reliable and reproducible are the results?

    Independent studies have raised questions about the reliability and reproducibility of this type of test, including variation in results from the same sample tested more than once in some cases. This is a key reason mainstream clinical bodies remain cautious about recommending it. If reliability matters to you, it's worth discussing established, evidence-based alternatives with your doctor.

  • Should I get a doctor's opinion before or after testing?

    Both — a conversation beforehand helps set realistic expectations about what the test can and can't tell you, and a conversation afterwards helps you interpret the result sensibly. A private GP or relevant specialist can give you a balanced, individual view rather than relying on marketing claims alone. This kind of guidance varies by provider and can save you from unnecessary worry or expense.